C2-ceramide signalling in glioma cells: Synergistic enhancement of CD95-mediated, caspase-dependent apoptosis

Cell Death and Differentiation

Volumn 8, Issue 6, 2001, Pages 595-602

  Wagenknecht, B ^a   Roth, W ^a   Gulbins, E ^b   Wolburg, H ^c   Weller, M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Apoptosis; Caspases; CD95 (APO 1, Fas); Ceramide; Glioma

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYLFLUOROMETHYL KETONE; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CERAMIDE; CYTOCHROME C; FAS ANTIGEN; LIGAND; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; DRUG DERIVATIVE; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; N ACETYLSPHINGOSINE; N-ACETYLSPHINGOSINE; PEPTIDE CHLOROMETHYL KETONE; SPHINGOSINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME RELEASE; EXPOSURE; GENE TRANSFER; GLIOMA CELL; HUMAN; HUMAN CELL; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GLIA; IMMUNOBLOTTING; METABOLISM; MITOCHONDRION; PATHOLOGY; ULTRASTRUCTURE;

AMINO ACID CHLOROMETHYL KETONES; ANTIGENS, CD95; APOPTOSIS; CASPASES; CYTOCHROME C GROUP; DRUG SYNERGISM; ENZYME ACTIVATION; FAS LIGAND PROTEIN; HUMANS; IMMUNOBLOTTING; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; MITOCHONDRIA; NEUROGLIA; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION; SPHINGOSINE; TUMOR CELLS, CULTURED;

EID: 0034743432     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400848     Document Type: Article

References (40)

1. Regulation of ceramide production and apoptosis
2. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation
3. Dexamethasone increases neutral sphingomyelinase activity and sphingosine levels in 3T3-L1 fibroblasts
4. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation
5. Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal
6. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signalling pathway
7. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition
8. The sphingomyelin cycle and the second messenger function of ceramide
9. CD95 (Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis
10. Ceramide activates the stress-activated protein kinases
11. Phosphorylation of Raf by ceramide-activated protein kinase
12. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
13. Kinase suppressor of Ras is ceramide-activated protein kinase
14. Characterization of a ceramide-activated protein kinase: Stimulation by tumor necrosis factor alpha
15. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction
16. Ceramide induces apoptosis via CPP32 activation
17. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing
18. Fas (APO-1/CD95) signaling pathway is intact in radioresistent human glioma cells
19. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines
20. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation
21. APO2 ligand: A novel lethal weapon against malignant glioma?
22. Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses
23. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells
24. Effect of more than one inhibitor
25. Fas/APO-1 gene transfer for human malignant glioma
26. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule
27. Substrate recognition by ceramide-activated protein kinase. Evidence that kinase activity is proline-directed
28. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase
29. Ceramide activates heterotrimeric protein phosphatase 2A
30. Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells
31. Involvement of lipid mediators on cytokine signaling and induction of secretory phospholipase A2 in immortalized astrocytes (DITNC)
32. Compartmentalization of ceramide signaling: Physical foundations and biological effects
33. Molecular characterization of mitochondrial apoptosis-inducing factor
34. Apoptosis without caspases: An inefficient molecular guillotine?
35. Bcl-2 prevents caspase-independent cell death
36. Immunochemotherapy of malignant glioma: Synergistic activity of CD95 ligand and chemotherapeutics
37. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53
38. Oncogene-dependent apoptosis is mediated by caspase-9
39. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release
40. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma